Disclosed are: a 2-(5-chloropyridine-3-vl)- 1-( 2,5-dichiorobenzvl)-4-methyl- lH-imidazole-5-carboxylic acid crystal, which is useful as a therapeutic agent or prophylactic agent against gout, hyperuricemia, and the like and a method for producing the same.